Analysis of flavonoid phytoestrogens in botanical and ephedra-containing dietary supplements

Annals of Pharmacotherapy

Volumn 41, Issue 9, 2007, Pages 1375-1382

  Grippo, Anne A ^a   Capps, Kayla ^a   Rougeau, Ben ^a   Gurley, Bill J ^b  

^a ARKANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Botanical supplements; Dietary supplements; Ephedra; Flavonoid; Isoflavone; Phytoestrogen

Indexed keywords

ALCOHOL; ALLPYRAL; BIOCHANIN A; CIMICIFUGA RACEMOSA EXTRACT; DAIDZEIN; ECHINACEA EXTRACT; EPHEDRA EXTRACT; ESTROGEN; FLAVONOID; FORMONONETIN; GENISTEIN; HYDROXYCUT; ISOFLAVONE DERIVATIVE; KAVA; METABOLIFE 356; METABOLIFT; OXEDRINE; PHYTOESTROGEN; QUERCETIN; RIPPED FUEL; SABAL EXTRACT; SILYBUM MARIANUM EXTRACT; STACKER 2; UNCLASSIFIED DRUG; VALERIAN; VIRGIN EARTH; XENADRINE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DIET SUPPLEMENTATION; DRUG FATALITY; DRUG SAFETY; DRUG STRUCTURE; EPHEDRA; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL; SEIZURE; STROKE; TABLET; UNITED STATES;

DIETARY SUPPLEMENTS; EPHEDRA; FLAVONOIDS; PHYTOESTROGENS; PLANT PREPARATIONS;

EID: 34548166996     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H497     Document Type: Article

References (38)

1. Ho P-C, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharmaceut Sci 2001;4:217-27.
2. Fels HE, Neil HG, Ralph IG, Suiter RJ. The effect of season on the ovulation rates of Merino and crossbred ewes in Western Australia. Aust J Agri Res 1969;9:267-71.
3. Lightfoot RJ, Crocker KP, Neil HG. Failure of sperm transport in relation to ewe infertility following prolonged grazing on oestrogenic pastures. Aust J Agri Res 1967;18:755-65.
4. Adams NR. Morphological changes in the organs of ewes grazing oestrogenic subterranean clover. Res Vet Sci 1977;22:216-21.
5. Adams NR. Detection of the effects of phytoestrogens on sheep and cattle. J Animal Sci 1995;73:1509-15.
6. Fritz WA, Eltoum I, Cotroneo MS, Lamartiniere CA. Genistein alters growth but is not toxic to the rat prostate. J Nutr 2002;132:3007-11.
7. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignanas and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991;54:1093-100.
8. This P, De la Rochefordie A, Clough K, Fourquet A, Magdelenat H. Phytoestrogens after breast cancer. Endocrine-Related Cancer 2001;8:129-34.
9. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
10. Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, Heck H. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors α and β in vitro. Toxicol Sci 1999;51:236-44.
11. Mann K, Borrás C, Knock GA, et al. Dietary soy isoflavone-induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J. Express. DOI 10.1096/fj.05-4008fje 2005. www.fasebj.org/cgi/reprint/05-4008fjev1 (accessed 23 May 2007).
12. Piontek M, Hangels KJ, Porschen R, Strohmeyer G. Anti-proliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res 1993;13:2119-23.
13. Boutin JA. Minireview - tyrosine protein kinase inhibition and cancer. Int J Biochem Cell Biol 1994;26:1203-26.
14. Whitten PL, Patisaul HB. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 2001;109(suppl 1):5-20.
15. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002;287:337-44.
16. US Food and Drug Administration Dietary Supplement Health and Education Act of 1994, Public Law 103-417, 103rd Congress. www.fda.gov/opacom/Laws/dshea. html (accessed 23 May 2007).
17. Gardner SF, Franks AM, Gurley BJ, Haller CA, Singh BK, Mehta JL. Effect of multicomponent, ephedra containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. Am J Cardiol 2003;91:1510-3.
18. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA 2004;291:216-21.
19. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
20. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6.
21. Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J Neurological Sci 2004;217:55-60.
22. Sola S, Helmy T, Kacharava A. Coronary dissection and thrombosis after ingestion of ephedra. Am J Med 2004;116:645-6.
23. Tyagi A, Delanty N. Herbal remedies, dietary supplements, and seizures. Epilepsia 2003;44:228-35.
24. Federal Register. 21 CFR Part 119. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule. Wednesday, February 11, 2004;69(28):6787-854.
25. Harris G, Schreiber J. Judge's decision lifts ban on sale of ephedra in Utah. New York Times April 15, 2005. www.nytimes.com/2005/04/15/health/ 15ephedra.html?ei=5070&en=448782262c6bffbb&ex=1184731200&adxnnl= 1&adxnnlx=118460-2426-pIzFQ19p//T79bHUcDrSig (accessed 2007 Jul 16).
26. Pray WS. Update on the regulatory status of ephedrine. Nonprescription Medicines Academy, 2007. www.nmafaculty.org/news/ephedrine.htm (accessed 23 May 2007).
27. Franke AA, Custer LJ. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B 1994;662:47-60.
28. Grippo AA, Xie Y, Rougeau B, Wyatt WV. Analysis of phytoestrogens by high pressure liquid chromatography. J Ark Acad Sci 1999;53:61-6.
29. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra containing dietary supplements. Am J Health Syst Pharm 2000;57:963-9.
30. Nwannenna A, Lundh TJ, Madej A, Fredriksson G, Bjornhag G. Clinical changes in ovariectomized ewes exposed to phytoestrogens and 17 beta-estradiol implants. Proc Soc Exp Biol Med 1995;208:92-7.
31. de Kleijn MJJ, van der Schouw YT, Wilson PW, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr 2001;131:1826-32.
32. Murkies AL, Wilcox G, Davis SR. Phytoestrogens. J Clin Endocrinol Metab 1998;83:297-303.
33. Cassidy A, Bingham S, Setchell KDR. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br Nutr J 1995;74:587-601.
34. Burton JL, Wells M. The effect of phytoestrogens on the female genital tract. J Clin Pathol 2002;55:401-7.
35. Anderson JW, Bryan MJ, Cook-Newell ME. Meta-analysis effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-86.
36. Erdman JW Jr. Soy protein and cardiovascular disease. Circulation 2000;102:2555-9.
37. FDA Talk Paper. FDA approves new health claim for soy protein and coronary heart disease. www.fda.gov/bbs/topics/ANSWERS/ANS00980.html (accessed 23 May 2007).
38. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health. Circulation 2006;113:1034-44.